Bormioli Pharma S.p.A Company Profile
>
Bormioli Pharma
Manufacturing
- Type
Public
- Headquarters
Italy
- Establishment
1825
- Key Management
Mr.Andrea Lodetti (CEO)
- Revenue
~ 271(2021)
- Headcount
~855(2021)
- Website
Business Description
Bormioli Pharma, a primary manufacturer of plastic and glass packaging for the pharmaceutical, nutraceutical, and biopharmaceutical markets is Bormioli Pharma. Products include dual-chamber systems and are geared towards drug delivery for nasal, parenteral, and oral use. Bormioli Pharma was established in 2017 when the London-based investment firm Triton Investments Advisers LLP acquired the pharma division of Bormioli Rocco, a glass manufacturer. Luigi Bormioli SpA also acquired Bormioli Rocco’s glass tableware business from Vision Capital.
Key Financials
Revenue (US$ Mn)
Operating Income (US$ Mn)
Net Income (US$ Mn)
Operating Margin %
Gross Margin %
SWOT Analysis
Strengths
Get this premium content
The Premium data is Locked
✖